Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?

Key Points Eli Lilly and Novo Nordisk make the world’s most popular weight loss drugs. These injectable products have generated double-digit growth, with revenue reaching blockbuster levels. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have seen revenue climb in recent years thanks to their expertise in one particular area: weight loss drugs. The companies are leaders in this market that analysts expect to reach nearly $100 billion by 2030. Today, they ...